Iraqi Science: Who Cares?

As my intrepid colleague Sam Jaffe reports in this issue (Rebuilding Iraqi Science), Iraqi science is on its knees. Following two-and-a-half decades of a brutal dictatorship, it's been pummeled by sanctions, halted in its tracks by war, and ransacked in the postwar chaos. We probably can add to this list a deep malaise, which appears to be affecting the entire country as it awaits reconstruction. While reading his report, several questions struck me: Just how worthwhile would it be to reconst

Written byRichard Gallagher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

As my intrepid colleague Sam Jaffe reports in this issue (Rebuilding Iraqi Science), Iraqi science is on its knees. Following two-and-a-half decades of a brutal dictatorship, it's been pummeled by sanctions, halted in its tracks by war, and ransacked in the postwar chaos. We probably can add to this list a deep malaise, which appears to be affecting the entire country as it awaits reconstruction.

While reading his report, several questions struck me: Just how worthwhile would it be to reconstruct the Iraqi science base? Who would benefit? And how might aid be provided quickly?

Obviously, the estimated 10,000 PhD researchers in Iraq would welcome the effort to rebuild their scientific community. This is a substantial body of scientists, particularly so for this region of the world, and one that could be put to good use.

For example, Iraq's education system was one of the region's best prior to 1991, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies